Pathogenesis of vasculitis

Lupus

Volumn 7, Issue 4, 1998, Pages 280-284

  Kallenberg, C G M ^a   Heeringa, P ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Anti neutrophil cytoplasmic antibodies; Pathophysiology; Systemic vasculitis; Wegener's granulomatosis

Indexed keywords

AUTOANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY;

AUTOIMMUNE DISEASE; BLOOD VESSEL WALL; HUMAN; IMMUNE COMPLEX DEPOSITION; INFECTION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SYSTEMIC VASCULITIS; VASCULITIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; HUMANS; T-LYMPHOCYTES; VASCULITIS;

EID: 0031779031     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/096120398678920109     Document Type: Review

References (46)

1. Somer T, Finegold SM. Vasculitides associated with infections, immunization and antimicrobial drugs. Clin Inf Dis 1995; 20: 1010-1036.
2. Hunder GG et al. The American College of Rheumatology 1990 criteria for the classification of vasculitis Arthritis Rheum 1990; 33: 1065-1067.
3. Jennette JC et al. Nomenclature of systemic vasculitides: the proposal of an international consensus conference Arthritis Rheum 1994; 37: 187-192.
4. Lie JT Nomenclature and classification of vasculitis: plus ça change, plus c'est la mêine chose. Arthritis Rheum 1994; 37: 181-186.
5. Theofilopoulos AN, Dixon FJ. Immune complexes in human diseases. Am J Pathol 1980; 100: 530-594.
6. Bruggen MCJ van, Berden JHM Central role for nucleosomes in lupus. Nephrol Dial Transplant 1996; 11: 1219-1222.
7. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992; 327: 1490-1495.
8. Guillevin L, Lhote F, Gherardi R. The spectrum and treatment of virus-associated vasculitides. Curr Op Rheumatol 1997; 9: 31-36.
9. Yousif Y et al. Staphylococcal neutral phosphatase. A highly cationic molecule with binding properties for immunoglobulin. APMIS 1991; 102: 897-900.
10. Kallenberg CGM. Laboratory findings in the vasculitides. Bailliere's Clin Rheumatol 1997; 11: 395-421.
11. Kallenberg CGM, Brouwer E, Weening JJ, Cohen Tervaert JW. Antineutrophil cytoplasmic antibodies: current diagnostic and pathophysiological potential. Kidney Int 1994; 46: 1-15.
12. Cohen Tervaert JW, Stegeman CA, Kallenberg CGM. Serial ANCA testing is useful in monitoring disease activity of patients with ANCA-associated vasculitides. Sarcoidosis 1996; 13: 241-245
13. Falk RJ, Terrell RS, Charles LA, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci 1990; 87: 4115-4119.
14. Reumaux D, Vossebeld PJM, Roos D, Verhoeven AJ. Effects of tumor necrosis factor-induced integrin activation on Fey receptor II-mediated signal transduction: relevance for activation of neutrophils by antiproteinase 3 or anti-myeloperoxidase antibodies. Blood 1995; 86: 3189-3195
15. Csernok E et al. Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo. Clin Exp Immunol 1994; 95: 244-250.
16. Gilligan HM et al. Antineutrophil cytoplasmic autoantibodies interact with primary granule constituents on the surface of apoptotic neutrophils in the absence of neutrophil priming. J Exp Med 1996; 184: 2231-2241.
17. Mulder AHL et al Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA); a FcγRII-dependent process. Clin Exp Immunol 1994; 78: 270-278.
18. Grimminger F et al. Neutrophil activation by anti-proteinase 3 antibodies in Wegener's Granulomatosis: Role of exogenous arachidonic acid and leukotriene B4 generation. J Exp Med 1996; 184: 1567-1572.
19. Brooks CJ et al IL-1β production by human polymorphonuclear leukocytes stimulated by anti-neutrophil cytoplasmic autoantibodies: relevance to systemic vasculitis. Clin Exp Immunol 1996; 106: 273-279.
20. Ewert BH, Jennette JC, Falk RJ The pathogenic role of anti-neutrophil cytoplasmic autoantibodies. Am J Kidney Dis 1991; 18: 188-195.
21. Casselman BL, Kilgore KS, Miller BF, Warren JS. Antibodies to neutrophil cytoplasmic antigens induce monocyte chemoattractant protein-1 secretion from human monocytes. J Lab Clin Med 1995; 126: 495-502.
22. Savage CO, Pottinger BE, Gaskin G, Pusey CD, Pearson JD. Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity towards cultured endothelial cells. Am J Path 1992; 141: 335-342.
23. Ewert BH, Jennette JC, Falk RJ. Anti-myeloperoxidase antibodies stimulate neutrophils to damage human endothelial cells. Kidney Int 1992; 41: 375-383.
24. Mayet WJ, Meyer zum Buschenfelde KH. Antibodies to proteinase 3 increase adhesion of neutrophils to human endothelial cells Clin Exp Immunol 1993; 94: 440-446
25. Mayet WJ, Schwarting A. Meyer zum Buschenfelde KH Cytotoxic effects of antibodies to proteinase 3 (C-ANCA) on human endothelial cells. Clin Exp Immunol 1994; 97: 458-465
26. Van der Wiel BA et al. Interference of Wegener's granulomatosis autoantibodies with neutrophil proteinase 3 activity. Clin Exp Immunol 1992; 90: 409-414.
27. Mayet WJ et al. Human endothelial cells express proteinase 3, the target antigen of anticytoplasmic antibodies in Wegener's Granulomatosis. Blood 1993; 82: 1221-1229.
28. King WJ et al. Endothelial cells and renal epithelial cells do not express the Wegener's autoantigen, proteinase 3. Clin Exp Immunol 1995; 102: 98-105
29. Heeringa P et al. Animal models of anti-neutrophil cytoplasmic antibody associated vasculitis. Kidney Int (in press).
30. Mathieson PW, Thiru S, Oliveira DBG. Mercuric chloride-treated Brown Norway rats develop widespread tissue injury including necrotizing vasculitis. Lab Invest 1992; 67: 121-129.
31. Hewicker M, Trautwein G. Sequential study of vasculitis in MRL mice. Lab Anim 1987; 21: 335-341.
32. Moyer CF, Strandberg DJ, Reinish CL. Systemic mononuclear cell vasculitis in MRL/Mp-lpr/lpr mice: a histological and immunocytochemical analysis. Am J Path 1987; 127: 229-242.
33. Harper JM, Lockwood CM, Cooke A. Anti-neutrophil cytoplasm antibody in MRL-lpr/lpr mice. Clin Exp Immunol 1993; 93(suppl 1): 22.
34. Kinjoh K, Kyogoku M, Good RA. Genetic selection for crescent formation yields mouse strain with rapidly progressive glomerulonephritis and small vessel vasculitis. Proc Natl Acad Sci 1993; 90: 3413-3417.
35. Brouwer E et al. Anti-myeloperoxidase associated proliferative glomerulonephritis; an animal model. J Exp Med 1993; 177: 905-914.
36. Yang JJ, Jennette JC, Falk RJ. Immune complex glomerulonephritis is induced in rats immunized with heterologous myeloperoxidase. Clin Exp Immunol 1994; 97: 466-473.
37. 2 in myeloperoxidase-immunized rats leads to necrotizing vasculitis in the lungs and gut Am J Path 1997; 151: 131-139.
38. Blank M et al. Immunization with anti-neutrophil cytoplasmic antibody (ANCA) induces the production of mouse ANCA and perivascular lymphocyte infiltration. Clin Exp Immunol 1995; 102: 120-130.
39. Stegeman CA et al. Association of chronic nasal carnage of Staphylococcus aureus and higher relapse rates in Wegener's granulomatosis. Ann Intern Med 1994; 113: 12-17.
40. Stegeman CA, Cohen Tervaert JW, Jong de PE, Kallenberg CGM. Trimethoprim (Cotrimoxazole) for the prevention of relapses of Wegener's granulomatosis. N Engl J Med 1996; 335: 16-20.
41. Brouwer E et al. T-cell reactivity to proteinase 3 and myeloperoxidase in patients with Wegener's granulomatosis. Clin Exp Immunol 1994; 98: 448-453.
42. Leung DYM et al. Evidence for superantigen involvement in cardiovascular injury due to Kawasaki syndrome. J Immunol 1995; 155: 5018-5021.
43. Simpson IJ et al. Peripheral blood T lymphocytes in systemic vasculitis: increased T cell receptor Vβ2 gene usage in microscopic polyarteritis. Clin Exp Immunol 1995; 101: 220-226.
44. Popa ER et al. Skewed TCR Vβ usage in Wegener's Granulomatosis suggests stimulation by superantigens. J Am Soc Nephrol 1997; 8: 543A.
45. Posnett DN, Sinha R, Kabak S, Russo C. Clonal populations of T cells in normal elderly humans: the T cell equivalents to 'benign monoclonal gammopathy'. J Exp Med 1994; 179: 609-618.
46. Weyand CM, Goronzy JJ. Multisystem interactions in the pathogenesis of vasculitis. Curr Op Rheumatol 1997; 9: 3-11.